Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 804,352
  • Shares Outstanding, K 51,528
  • Annual Sales, $ 18,660 K
  • Annual Income, $ -132,690 K
  • 60-Month Beta 0.53
  • Price/Sales 38.27
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.65
  • Number of Estimates 3
  • High Estimate -0.57
  • Low Estimate -0.75
  • Prior Year -2.20
  • Growth Rate Est. (year over year) +70.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.77 +130.58%
on 03/16/20
15.69 -0.51%
on 04/03/20
+4.83 (+44.81%)
since 03/03/20
3-Month
3.65 +327.46%
on 01/13/20
17.71 -11.86%
on 02/28/20
+11.17 (+251.58%)
since 01/03/20
52-Week
3.54 +340.96%
on 11/21/19
17.71 -11.86%
on 02/28/20
+3.72 (+31.26%)
since 04/03/19

Most Recent Stories

More News
Stocks Move Lower but Stay Calm After Dreary Jobs Report

Stocks Move Lower but Stay Calm After Dreary Jobs Report

CNR : 4.17 (+4.77%)
URI : 91.07 (-5.29%)
AIMT : 13.36 (-4.16%)
CLDR : 7.35 (-4.17%)
NWL : 11.99 (-0.66%)
JCAP : 10.62 (+0.66%)
NVAX : 15.61 (+12.63%)
JCOM : 68.36 (-1.63%)
LLY : 139.66 (-1.77%)
Novavax (NVAX): Strong Industry, Solid Earnings Estimate Revisions

Novavax (NVAX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

NVAX : 15.61 (+12.63%)
Coronavirus Drug & Vaccine: 4 Companies Leading From the Front

The present scenario has brightened up prospects for companies working on potential drugs and vaccines to combat the pandemic.

JNJ : 134.17 (+0.77%)
SNY : 44.83 (+3.03%)
MRNA : 34.84 (+4.94%)
NVAX : 15.61 (+12.63%)
The Threat of Infectious Diseases Impulses Governments and Businesses Towards Adjustments

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi and parasites, and can be transmitted by direct or indirect contact. Worldwide, infectious diseases such as...

LITH : 0.7400 (-6.33%)
CODX : 8.20 (-3.64%)
VIR : 29.00 (-0.89%)
NVAX : 15.61 (+12.63%)
MRNA : 34.84 (+4.94%)
Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know

Novavax (NVAX) closed the most recent trading day at $13.86, moving -1.21% from the previous trading session.

NVAX : 15.61 (+12.63%)
Coronavirus Vaccine Race Intensifies: 3 Stocks in Focus

Given the urgent need for preventing the spread of COVID-19 in future, let's take a look at the companies developing vaccines for the same.

JNJ : 134.17 (+0.77%)
SNY : 44.83 (+3.03%)
MRNA : 34.84 (+4.94%)
NVAX : 15.61 (+12.63%)
TBIO : 9.53 (+4.84%)
Shares of NVAX Up 33.9% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Novavax Inc (NASDAQ:NVAX) on March 18th, 2020 at $10.14. In approximately 2 weeks, Novavax Inc has returned 33.93% as of today's recent price of $13.58.

NVAX : 15.61 (+12.63%)
Biotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development

The rampant race to introduce a vaccine for the COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.

JNJ : 134.17 (+0.77%)
SNY : 44.83 (+3.03%)
DVAX : 3.17 (-8.38%)
PFE : 33.64 (+2.34%)
MRNA : 34.84 (+4.94%)
GSK : 37.14 (-1.49%)
NVAX : 15.61 (+12.63%)
TBIO : 9.53 (+4.84%)
EBS : 57.66 (+1.10%)
IBB : 106.25 (-1.35%)
XLV : 86.78 (-0.90%)
IMV : 1.6900 (+6.96%)
VHT : 162.13 (-1.12%)
HTBX : 0.5000 (-7.77%)
XBI : 74.86 (-1.41%)
Vaccine for COVID-19 Health Crises "Possible" by Summer After FDA Fast-Tracks Clinical Trials

The World House has called on U.S. health regulators to expedite potential therapies aimed at treating COVID-19 amid the fast-spreading coronavirus outbreak, saying it could lead to a breakthrough while...

CTXR : 0.7444 (+0.61%)
KNSA : 17.91 (+6.35%)
CYDY : 2.7900 (+18.72%)
NVAX : 15.61 (+12.63%)
ATHX : 2.88 (+5.11%)
Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu(TM)

-- CDMO agreement for NanoFlu to support pathway to licensure

EBS : 57.66 (+1.10%)
NVAX : 15.61 (+12.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade NVAX with:

Business Summary

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as...

See More

Key Turning Points

2nd Resistance Point 17.06
1st Resistance Point 16.33
Last Price 15.61
1st Support Level 14.24
2nd Support Level 12.88

See More

52-Week High 17.71
Last Price 15.61
Fibonacci 61.8% 12.30
Fibonacci 50% 10.63
Fibonacci 38.2% 8.95
52-Week Low 3.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar